 Rebecca McCullough
Concepts (206)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Diseases, Alcoholic | 16 | 2022 | 84 | 4.380 |
Why?
| | Ethanol | 20 | 2023 | 548 | 2.780 |
Why?
| | Hepatocytes | 6 | 2022 | 196 | 1.420 |
Why?
| | Liver | 14 | 2023 | 1681 | 1.200 |
Why?
| | Receptor, Anaphylatoxin C5a | 2 | 2018 | 28 | 1.150 |
Why?
| | Binge Drinking | 1 | 2023 | 32 | 0.880 |
Why?
| | Aldehydes | 6 | 2014 | 142 | 0.820 |
Why?
| | Neurodegenerative Diseases | 1 | 2023 | 91 | 0.810 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2022 | 125 | 0.760 |
Why?
| | Fatty Acids | 3 | 2022 | 385 | 0.750 |
Why?
| | Inflammation | 7 | 2023 | 2485 | 0.740 |
Why?
| | Alcoholism | 3 | 2022 | 716 | 0.680 |
Why?
| | Cognitive Dysfunction | 1 | 2023 | 273 | 0.680 |
Why?
| | Mice, Inbred C57BL | 17 | 2022 | 4718 | 0.670 |
Why?
| | PTEN Phosphohydrolase | 4 | 2016 | 140 | 0.610 |
Why?
| | Mice | 24 | 2023 | 14927 | 0.570 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2018 | 192 | 0.550 |
Why?
| | Protein Carbonylation | 5 | 2016 | 51 | 0.550 |
Why?
| | MAP Kinase Kinase Kinases | 1 | 2016 | 68 | 0.520 |
Why?
| | Myeloid Cells | 1 | 2016 | 127 | 0.490 |
Why?
| | Adipose Tissue | 1 | 2018 | 558 | 0.480 |
Why?
| | Animals | 27 | 2023 | 31867 | 0.420 |
Why?
| | Fatty Acid-Binding Proteins | 3 | 2013 | 61 | 0.390 |
Why?
| | Fatty Liver | 3 | 2014 | 217 | 0.380 |
Why?
| | Hepatitis, Alcoholic | 2 | 2021 | 13 | 0.380 |
Why?
| | Proto-Oncogene Proteins c-akt | 3 | 2016 | 400 | 0.380 |
Why?
| | Fatty Liver, Alcoholic | 2 | 2016 | 16 | 0.350 |
Why?
| | AMP-Activated Protein Kinases | 2 | 2014 | 175 | 0.310 |
Why?
| | Lipid Peroxidation | 3 | 2014 | 139 | 0.280 |
Why?
| | Diet, High-Fat | 3 | 2020 | 225 | 0.270 |
Why?
| | Disease Models, Animal | 7 | 2020 | 3545 | 0.260 |
Why?
| | Public Opinion | 2 | 2023 | 59 | 0.260 |
Why?
| | Mice, Knockout | 5 | 2021 | 2585 | 0.260 |
Why?
| | Proteins | 2 | 2012 | 915 | 0.250 |
Why?
| | Non-alcoholic Fatty Liver Disease | 2 | 2020 | 246 | 0.250 |
Why?
| | Apoptosis | 4 | 2018 | 2366 | 0.240 |
Why?
| | Ethyl Ethers | 1 | 2022 | 4 | 0.210 |
Why?
| | Proteomics | 4 | 2021 | 844 | 0.210 |
Why?
| | Transendothelial and Transepithelial Migration | 1 | 2023 | 29 | 0.210 |
Why?
| | Glycoproteins | 2 | 2021 | 305 | 0.210 |
Why?
| | Alcohol Drinking | 2 | 2020 | 655 | 0.200 |
Why?
| | Central Nervous System Depressants | 2 | 2018 | 82 | 0.200 |
Why?
| | Cytokines | 3 | 2018 | 1843 | 0.200 |
Why?
| | Complement Factor D | 2 | 2020 | 27 | 0.200 |
Why?
| | Oxidative Stress | 6 | 2016 | 1085 | 0.200 |
Why?
| | Fluorocarbons | 1 | 2023 | 94 | 0.190 |
Why?
| | Protein Phosphatase 2 | 1 | 2021 | 30 | 0.190 |
Why?
| | Endoplasmic Reticulum | 2 | 2014 | 234 | 0.190 |
Why?
| | Mitochondria, Liver | 1 | 2011 | 66 | 0.180 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2021 | 95 | 0.180 |
Why?
| | Sirtuin 3 | 1 | 2011 | 52 | 0.180 |
Why?
| | Multigene Family | 1 | 2011 | 194 | 0.180 |
Why?
| | Lipoproteins, LDL | 1 | 2020 | 129 | 0.170 |
Why?
| | Lymphatic Vessels | 1 | 2020 | 54 | 0.170 |
Why?
| | Sarcopenia | 1 | 2021 | 63 | 0.170 |
Why?
| | Kupffer Cells | 2 | 2017 | 45 | 0.170 |
Why?
| | Tandem Mass Spectrometry | 4 | 2021 | 413 | 0.170 |
Why?
| | Premature Birth | 1 | 2023 | 277 | 0.170 |
Why?
| | Models, Molecular | 4 | 2014 | 1379 | 0.160 |
Why?
| | Sulfhydryl Compounds | 1 | 2011 | 177 | 0.160 |
Why?
| | Anaphylatoxins | 1 | 2018 | 6 | 0.160 |
Why?
| | Blotting, Western | 2 | 2016 | 1149 | 0.160 |
Why?
| | Adipokines | 1 | 2018 | 43 | 0.160 |
Why?
| | Gastrointestinal Tract | 1 | 2020 | 169 | 0.150 |
Why?
| | Primary Cell Culture | 1 | 2018 | 149 | 0.150 |
Why?
| | Protective Agents | 1 | 2018 | 38 | 0.150 |
Why?
| | Rats | 4 | 2017 | 4973 | 0.150 |
Why?
| | Female | 10 | 2023 | 59617 | 0.150 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2023 | 450 | 0.150 |
Why?
| | Extracellular Vesicles | 1 | 2018 | 83 | 0.140 |
Why?
| | Phosphorylation | 2 | 2016 | 1572 | 0.140 |
Why?
| | Evolution, Molecular | 1 | 2011 | 437 | 0.140 |
Why?
| | Complement Pathway, Alternative | 1 | 2018 | 114 | 0.140 |
Why?
| | Adipocytes | 1 | 2018 | 189 | 0.140 |
Why?
| | Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2016 | 13 | 0.140 |
Why?
| | MAP Kinase Kinase 4 | 1 | 2016 | 23 | 0.140 |
Why?
| | Immune System | 1 | 2018 | 172 | 0.140 |
Why?
| | Chemical and Drug Induced Liver Injury, Chronic | 1 | 2016 | 9 | 0.130 |
Why?
| | Immunohistochemistry | 2 | 2016 | 1634 | 0.130 |
Why?
| | Complement C1q | 1 | 2016 | 38 | 0.130 |
Why?
| | Intestinal Mucosa | 1 | 2020 | 528 | 0.130 |
Why?
| | Amino Acid Sequence | 4 | 2014 | 1990 | 0.130 |
Why?
| | Rats, Wistar | 1 | 2016 | 369 | 0.120 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2016 | 315 | 0.120 |
Why?
| | Toll-Like Receptor 4 | 1 | 2017 | 286 | 0.120 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2017 | 386 | 0.120 |
Why?
| | Immunoglobulin M | 1 | 2016 | 251 | 0.120 |
Why?
| | Gastrointestinal Microbiome | 1 | 2020 | 502 | 0.120 |
Why?
| | Humans | 19 | 2023 | 115047 | 0.110 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2014 | 91 | 0.110 |
Why?
| | Heat-Shock Proteins | 1 | 2014 | 113 | 0.110 |
Why?
| | Adenosine Triphosphatases | 1 | 2014 | 155 | 0.110 |
Why?
| | Male | 16 | 2021 | 55735 | 0.110 |
Why?
| | Complement Activation | 1 | 2016 | 340 | 0.110 |
Why?
| | Lipopolysaccharides | 1 | 2016 | 817 | 0.110 |
Why?
| | Molecular Sequence Data | 3 | 2011 | 2796 | 0.100 |
Why?
| | MicroRNAs | 1 | 2017 | 603 | 0.100 |
Why?
| | Dietary Fats | 1 | 2013 | 290 | 0.090 |
Why?
| | Gene Expression Regulation | 3 | 2017 | 2329 | 0.090 |
Why?
| | Chromatography, Liquid | 2 | 2013 | 348 | 0.090 |
Why?
| | Enzyme Activation | 2 | 2013 | 791 | 0.090 |
Why?
| | Protein Conformation | 1 | 2012 | 811 | 0.080 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 2 | 2012 | 101 | 0.070 |
Why?
| | Homeostasis | 2 | 2021 | 578 | 0.070 |
Why?
| | Immunoprecipitation | 2 | 2021 | 152 | 0.070 |
Why?
| | Biomarkers | 3 | 2021 | 3419 | 0.070 |
Why?
| | DNA Primers | 2 | 2012 | 514 | 0.070 |
Why?
| | Rats, Sprague-Dawley | 2 | 2011 | 2212 | 0.070 |
Why?
| | Protein Structure, Tertiary | 2 | 2014 | 798 | 0.060 |
Why?
| | Signal Transduction | 4 | 2017 | 4525 | 0.060 |
Why?
| | Cells, Cultured | 2 | 2023 | 3896 | 0.060 |
Why?
| | Cysteine Proteinase Inhibitors | 1 | 2014 | 45 | 0.060 |
Why?
| | Hep G2 Cells | 1 | 2014 | 61 | 0.060 |
Why?
| | Alanine Transaminase | 2 | 2016 | 140 | 0.060 |
Why?
| | Hawaii | 1 | 2023 | 38 | 0.050 |
Why?
| | Heme | 1 | 2023 | 52 | 0.050 |
Why?
| | Dehydroepiandrosterone | 1 | 2023 | 49 | 0.050 |
Why?
| | Triglycerides | 2 | 2016 | 471 | 0.050 |
Why?
| | Thiobarbituric Acid Reactive Substances | 1 | 2012 | 20 | 0.050 |
Why?
| | Models, Chemical | 1 | 2014 | 250 | 0.050 |
Why?
| | Cytochrome P-450 CYP3A | 1 | 2023 | 62 | 0.050 |
Why?
| | Malondialdehyde | 1 | 2012 | 28 | 0.050 |
Why?
| | Acrolein | 1 | 2012 | 23 | 0.050 |
Why?
| | Tretinoin | 1 | 2023 | 124 | 0.050 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2013 | 474 | 0.050 |
Why?
| | Eye Proteins | 1 | 2021 | 71 | 0.050 |
Why?
| | Pregnancy | 2 | 2023 | 5520 | 0.050 |
Why?
| | Iron | 1 | 2023 | 234 | 0.050 |
Why?
| | Microsomes, Liver | 1 | 2011 | 56 | 0.050 |
Why?
| | Complement C2 | 1 | 2020 | 6 | 0.050 |
Why?
| | NAD | 1 | 2011 | 64 | 0.050 |
Why?
| | Complement C5 | 1 | 2020 | 73 | 0.050 |
Why?
| | Complement C4 | 1 | 2020 | 26 | 0.050 |
Why?
| | Intercellular Junctions | 1 | 2020 | 33 | 0.050 |
Why?
| | Glycosylation | 1 | 2011 | 131 | 0.050 |
Why?
| | Proteostasis | 1 | 2020 | 20 | 0.050 |
Why?
| | Myoblasts | 1 | 2021 | 77 | 0.050 |
Why?
| | Acetylation | 1 | 2011 | 211 | 0.040 |
Why?
| | Sequence Alignment | 1 | 2011 | 325 | 0.040 |
Why?
| | Permeability | 1 | 2020 | 148 | 0.040 |
Why?
| | Boston | 1 | 2020 | 75 | 0.040 |
Why?
| | Organ Specificity | 1 | 2020 | 270 | 0.040 |
Why?
| | Microscopy, Confocal | 1 | 2011 | 305 | 0.040 |
Why?
| | Complement Factor B | 1 | 2020 | 100 | 0.040 |
Why?
| | Birth Weight | 1 | 2023 | 440 | 0.040 |
Why?
| | Species Specificity | 1 | 2011 | 548 | 0.040 |
Why?
| | Water | 1 | 2023 | 409 | 0.040 |
Why?
| | Complement C3 | 1 | 2020 | 189 | 0.040 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2011 | 171 | 0.040 |
Why?
| | Membrane Glycoproteins | 1 | 2021 | 429 | 0.040 |
Why?
| | Drosophila melanogaster | 1 | 2011 | 191 | 0.040 |
Why?
| | Genome, Human | 1 | 2011 | 351 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 187 | 0.040 |
Why?
| | Cell Movement | 1 | 2023 | 866 | 0.040 |
Why?
| | Congresses as Topic | 1 | 2020 | 198 | 0.040 |
Why?
| | Tumor Suppressor Proteins | 1 | 2020 | 282 | 0.040 |
Why?
| | Polymerase Chain Reaction | 1 | 2011 | 999 | 0.040 |
Why?
| | Epigenesis, Genetic | 1 | 2022 | 524 | 0.040 |
Why?
| | Caenorhabditis elegans | 1 | 2011 | 269 | 0.040 |
Why?
| | Protein Binding | 2 | 2014 | 1898 | 0.040 |
Why?
| | Complement System Proteins | 1 | 2020 | 285 | 0.040 |
Why?
| | Recombinant Proteins | 1 | 2011 | 1237 | 0.040 |
Why?
| | Base Sequence | 1 | 2011 | 2119 | 0.040 |
Why?
| | Homeodomain Proteins | 1 | 2020 | 464 | 0.030 |
Why?
| | Endothelium, Vascular | 1 | 2023 | 850 | 0.030 |
Why?
| | Complement C1 Inactivator Proteins | 1 | 2016 | 6 | 0.030 |
Why?
| | Complement C1 Inhibitor Protein | 1 | 2016 | 7 | 0.030 |
Why?
| | Hyaluronic Acid | 1 | 2017 | 189 | 0.030 |
Why?
| | Lipogenesis | 1 | 2016 | 57 | 0.030 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2016 | 85 | 0.030 |
Why?
| | Random Allocation | 1 | 2016 | 336 | 0.030 |
Why?
| | Solubility | 1 | 2016 | 224 | 0.030 |
Why?
| | Cell Death | 1 | 2016 | 324 | 0.030 |
Why?
| | Glutathione | 1 | 2016 | 302 | 0.030 |
Why?
| | Cytochrome P-450 CYP4A | 1 | 2014 | 4 | 0.030 |
Why?
| | CD36 Antigens | 1 | 2014 | 37 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2011 | 2715 | 0.030 |
Why?
| | Unfolded Protein Response | 1 | 2014 | 43 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2020 | 3015 | 0.030 |
Why?
| | Age Factors | 1 | 2020 | 2894 | 0.030 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2013 | 33 | 0.030 |
Why?
| | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2013 | 24 | 0.030 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 1 | 2013 | 54 | 0.030 |
Why?
| | Prognosis | 1 | 2020 | 3334 | 0.030 |
Why?
| | Protein Folding | 1 | 2014 | 239 | 0.030 |
Why?
| | Anilino Naphthalenesulfonates | 1 | 2012 | 10 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2017 | 1138 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2018 | 723 | 0.030 |
Why?
| | Ubiquitination | 1 | 2012 | 86 | 0.030 |
Why?
| | Organ Size | 1 | 2013 | 444 | 0.020 |
Why?
| | Adiponectin | 1 | 2013 | 212 | 0.020 |
Why?
| | Cloning, Molecular | 1 | 2012 | 524 | 0.020 |
Why?
| | Cholesterol | 1 | 2013 | 368 | 0.020 |
Why?
| | Macrophages | 1 | 2017 | 1267 | 0.020 |
Why?
| | Aging | 1 | 2020 | 1624 | 0.020 |
Why?
| | Computer Simulation | 1 | 2014 | 881 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 928 | 0.020 |
Why?
| | Lipids | 1 | 2013 | 586 | 0.020 |
Why?
| | Mass Spectrometry | 1 | 2012 | 634 | 0.020 |
Why?
| | Nuclear Proteins | 1 | 2013 | 593 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2013 | 1955 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2013 | 2563 | 0.020 |
Why?
| | Transcription Factors | 1 | 2013 | 1531 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2013 | 2108 | 0.010 |
Why?
| | Middle Aged | 1 | 2020 | 26830 | 0.010 |
Why?
| | Adult | 1 | 2020 | 30658 | 0.010 |
Why?
|
|
McCullough's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|